Skip to content
Screener

Heartflow, Inc. HTFL Operating Cash Flow

Operating Cash Flow at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$168M+78.7%
ITG
Integer HoldingsITGR
$24.7M-21.0%
Boston Scientific logo
Boston ScientificBSX
$348M-35.7%
Medtronic logo
MedtronicMDT
$2.57B+1.8%
Cytek Biosciences, Inc. logo
Cytek Biosciences, Inc.CTKB
-$2.74M-2,089%
Edwards Lifesciences logo
Edwards LifesciencesEW
$43.8M-84.4%

Other financials

Income statement

See full
Revenue$52.6M+41.3%
Gross profit$42.2M+50.9%
Operating income-$29.5M-68.6%
Net income-$27.4M+15.4%
EPS (diluted)-$0.32+93.9%

Balance sheet

See full
Cash & equivalents$24.4M-78.7%
Total debt$26.3M
Total equity$285.7M+132%
Total assets$344.0M

Cash flow

See full
CapEx$1.9M+71.6%
Free cash flow-$32.0M-124%

Valuation

See full
Market cap$2.34B-3.7%
Enterprise value$2.35B
P/S12.3×

Profitability

See full
Gross margin78.1%+2.4pp
Operating margin-39.7%-4.8pp
Net margin-58.4%-12.1pp
FCF margin-40.1%-2.4pp

Returns & leverage

See full
Return on equity37.1%
Debt / equity0.1×
Current ratio5.6×

Where this comes from

Reported directly by Heartflow, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Heartflow, Inc.’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 4:31 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001464521-26-000071
Line itemThree Months Ended / March 31, 2026Three Months Ended / March 31, 2025
Accrued expenses and other current liabilities(7,393)9,301
Operating lease liabilities(981)(888)
Other non-current liabilities1934
Net cash used in operating activities(30,104)(13,166)
Cash flows from investing activities:
Purchase of property and equipment(1,889)(1,101)
Purchase of investments(29,538)
Maturities of investments30,000

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Heartflow, Inc.'s operating cash flow?
Heartflow, Inc. (HTFL) reported operating cash flow of -$30.1M in Q1 2026.
How has Heartflow, Inc.'s operating cash flow changed year-over-year?
Heartflow, Inc.'s operating cash flow decreased by 128.6% year-over-year, from -$13.17M to -$30.1M.
What is the long-term trend for Heartflow, Inc.'s operating cash flow?
Over 2 years (2023 to 2025), Heartflow, Inc.'s operating cash flow has grown at a -15.9% compound annual growth rate (CAGR), from -$76.43M to -$54.02M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Heartflow, Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude